Facebook Pixel

The FDA Puts 27 Drugs on Watch List: Is Yours One?

By Expert HERWriter
Rate This

Millions of Americans start out their day swallowing their necessary medications. We place our trust in healthcare providers for their expertise, in our pharmacists for their experience and the drug companies for their research. Many medications are required for living, staving off symptoms or curing disease yet how many of you experience the laundry list of side effects as reported by that particular drug company.

Perhaps you have fatigue, diarrhea, constipation, rash, nausea, or weight gain. Maybe you endure the muscle pains, hair loss, indigestion, headache, dry mouth, sweating, or tremor. Even worse, some experience side effects not even listed but directly linked.

It is the job of the US Food and Drug Administration (FDA) to review each and every medication initially put on the market, and then monitors it over the progressive months and years. They do this with the help of Adverse Event Reporting System (AERS) which is an online site anyone can review and submit information to.

Based on this information, the FDA creates a to-watch list and for 2010, 27 medications have landed there. The FDA is very clear that the list is to evaluate potential concerns and is not a guaranteed removal from the market nor does it want healthcare providers to stop prescribing or consumers to stop taking these medications (unless, of course, you are experiencing the side effects).

For a full view of the list, you can visit www.medscape.com/viewarticle/717321, or visit the website for the FDA at www.fda.gov. I want to point out a few that I see many patients using on a regular basis.

Gabapentin (neurontin), a pain medication, is under FDA review for drug reaction with eosinophilia and systemic symptoms which includes high fever, rash and inflammation of one or more organs that can be severe.

Oseltamivir phosphate (Tamiflu) which has been commonly prescribed for the flu (including swine flu) is under FDA review for hypothermia.

Simvastatin (Zocor) and Diltiazem (Cardizem) which are cardiovascular drugs are under review for possible improper labeling about myopathy.

Add a Comment1 Comments

On November 18, 2004, Dr. David Graham, associate director in the FDA’s Office of Drug Safety gave
senate testimony that Crestor was one of five drugs with safety concerns. The drug causes muscle
breakdown and renal failure. Now we hear the same warnings for Zocor.

The truth is that women don't benefit from Zocor, Crestor, Lipitor or any other statin drug for
elevated cholesterol. There are no statin trials with even the slightest hint of a mortality
benefit in women, and women should be told so. In the elderly, a lower cholesterol level is
associated wih higher mortality.

To read more: http://www.drdach.com/Cholesterol_Women_Dr_Dach.html

Jeffrey Dach MD

March 21, 2010 - 7:28am
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy
Add a Comment

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

High Cholesterol

Get Email Updates

Related Checklists

High Cholesterol Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!